Open AccessVaccine Effectiveness Against Influenza A(H3N2)–Associated Hospitalized Illness: United States, 2022
Author(s) -
Mark W. Tenforde,
Manish M. Patel,
Nathaniel M. Lewis,
Katherine Adams,
Manjusha Gaglani,
Jay S. Steingrub,
Nathan I. Shapiro,
Abhijit Duggal,
Matthew E. Prekker,
Ithan D. Peltan,
David N. Hager,
Michelle N. Gong,
Matthew C. Exline,
Adit A. Ginde,
Nicholas M. Mohr,
Christopher Mallow,
Emily T. Martin,
H. Keipp Talbot,
Kevin W. Gibbs,
Jennie H. Kwon,
James D. Chappell,
Natasha Halasa,
Adam S. Lauring,
Christopher J. Lindsell,
Sydney A. Swan,
Kimberly W. Hart,
Kelsey N. Womack,
Adrienne Baughman,
Carlos G. Grijalva,
Wesley H. Self
Publication year - 2022
Publication title -
clinical infectious diseases
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciac869
Subject(s) - medicine , vaccination , influenza vaccine , confounding , pandemic , human mortality from h5n1 , influenza season , immunology , epidemiology , virus , odds ratio , virology , covid-19 , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom